Monopar Therapeutics — insider transactions
3 transactions on record · CIK 1645469
Aggregates
computed from the filings belowPurchases, 12m
0
count of open-market buys
Sales, 12m
3
count of open-market sales
Buy / sell ratio, 12m
0.00
purchases per sale
Distinct insiders, 12m
1
Bought, 3m
$0
Sold, 3m
$351.2K
Median disclosure lag
2.0 d
trade date to filing date
Largest single trade, 24m
$203.7K
2026-08-25
Director share, 12m
100.0%
of transactions where role is stated
Current run
3 sells
consecutive same-direction transactions
Net 3m flow
-$351.2K
purchases minus sales
Total on record
3
Transactions
3 most recent shown| Disclosed | Traded | Lag, d | Insider | Role | Transaction | Shares | Price | Value | Source |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-27 | 2026-08-25 | 2 | Anderson Raymond | Director | Open market sale | 1,802 | $113.05 | $203.7K | filing |
| 2026-08-27 | 2026-08-25 | 2 | Anderson Raymond | Director | Open market sale | 694 | $110.04 | $76.4K | filing |
| 2026-08-27 | 2026-08-25 | 2 | Anderson Raymond | Director | Open market sale | 646 | $110.07 | $71.1K | filing |